Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
FDA-approved for treating obesity, as well as other conditions, including sleep apnea, the medications are increasingly being used off-label by people who dont qualify based on factors like their BMI (which has long been a controversial measure of health, FWIW)
in Value in Health modeled lifetime costs and quality-adjusted life years (QALYs) for three strategies: Indefinite semaglutide treatment 1-year treatment followed by discontinuation No pharmacotherapy (behavioral intervention only) For patients who lost 15%+ body weight on treatment, indefinite continuation was cost-effective at a willingness-to-pay threshold of $100,000 per QALY, primarily due to reduced diabetes and cardiovascular disease costs
It has done absolutely NOTHING for me for weight loss, one person reported
Raisins add excellent flavor to just about any type of sweet spread
